<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.4: Glycemic Control: Insulin Sensitivity and Metabolic Syndrome</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL/GOLD theme for Endocrine */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #0f766e 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #0d9488;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #134e4a;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #0f766e 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #0d9488, #0f766e);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            color: #0d9488;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Statistics Box */
        .stats-highlight {
            background: linear-gradient(135deg, #0d9488 0%, #0f766e 100%);
            padding: 30px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
            display: flex;
            justify-content: space-around;
            text-align: center;
            flex-wrap: wrap;
            gap: 20px;
        }

        .stat-item {
            flex: 1;
            min-width: 150px;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Alert Box */
        .alert-box.info {
            background: #f0f9ff;
            border-left: 5px solid #0ea5e9;
            padding: 20px;
            border-radius: 0 12px 12px 0;
            margin: 30px 0;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdfa;
            border-radius: 8px;
            color: #134e4a;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 14px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: The Endocrine System & Metabolic Balance</p>
            <h1 class="lesson-title">Lesson 13.4: Glycemic Control: Insulin Sensitivity and Metabolic Syndrome</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#pathophysiology"><span class="section-num">1</span>Insulin Resistance & GLUT-4</a></li>
                <li><a href="#mets"><span class="section-num">2</span>Metabolic Syndrome Criteria</a></li>
                <li><a href="#berberine"><span class="section-num">3</span>Berberine vs. Metformin</a></li>
                <li><a href="#synergy"><span class="section-num">4</span>Organizing Synergistic Formulas</a></li>
                <li><a href="#tradition"><span class="section-num">5</span>Traditional Wisdom: Bitters</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application & Safety</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular pathophysiology of insulin resistance, specifically GLUT-4 translocation.</li>
                <li>Evaluate the comparative clinical efficacy of Berberine and Metformin in glycemic management.</li>
                <li>Master the 'O' (Organize) pillar of the R.O.O.T.S. Methodâ„¢ to formulate for metabolic synergy.</li>
                <li>Integrate 'T' (Traditional Wisdom) regarding bitter tonics into modern dietary protocols.</li>
                <li>Assess the impact of botanical interventions on HbA1c and fasting blood glucose (FBG) levels.</li>
            </ul>
        </div>

        <h2 id="pathophysiology">1. The Pathophysiology of Insulin Resistance</h2>
        <p>At the core of metabolic dysfunction lies <span class="highlight">insulin resistance (IR)</span>â€”a state where cells in the muscles, fat, and liver do not respond appropriately to insulin and cannot easily take up glucose from the blood. While previous lessons explored the HPA axis and Thyroid, we must now address the primary driver of modern chronic disease: the failure of glucose disposal.</p>

        <p>The molecular "gatekeeper" of glucose entry into the cell is <span class="highlight">GLUT-4 (Glucose Transporter Type 4)</span>. In a healthy state, insulin binds to its receptor, triggering a signaling cascade that causes GLUT-4 vesicles to move from the intracellular space to the cell membrane (translocation). In IR, this translocation is impaired. This is often driven by systemic inflammation originating in visceral adipose tissue, where pro-inflammatory cytokines like TNF-Î± and IL-6 interfere with insulin signaling pathways.</p>

        <div class="stats-highlight">
            <div class="stat-item">
                <span class="stat-number">88%</span>
                <span class="stat-label">of US Adults Metabolically Unhealthy</span>
            </div>
            <div class="stat-item">
                <span class="stat-number">38%</span>
                <span class="stat-label">Prevalence of MetS in Adults</span>
            </div>
            <div class="stat-item">
                <span class="stat-number">5-10yr</span>
                <span class="stat-label">Lag Before Type 2 Diagnosis</span>
            </div>
        </div>

        <h2 id="mets">2. Metabolic Syndrome: The R.O.O.T.S. Assessment</h2>
        <p>As a practitioner using the <span class="highlight">R.O.O.T.S. Herbalism Methodâ„¢</span>, you must <i>Observe</i> (O) the pattern of Metabolic Syndrome (MetS). MetS is not a single disease but a cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Parameter</th>
                        <th>Conventional Threshold</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Waist Circumference</strong></td>
                        <td>&gt;40" (M), &gt;35" (F)</td>
                        <td>Indicates visceral adiposity and portal inflammation.</td>
                    </tr>
                    <tr>
                        <td><strong>Triglycerides</strong></td>
                        <td>&ge;150 mg/dL</td>
                        <td>Marker of hepatic de novo lipogenesis from excess sugar.</td>
                    </tr>
                    <tr>
                        <td><strong>HDL Cholesterol</strong></td>
                        <td>&lt;40 (M), &lt;50 (F) mg/dL</td>
                        <td>Loss of cardiovascular protective factors.</td>
                    </tr>
                    <tr>
                        <td><strong>Blood Pressure</strong></td>
                        <td>&ge;130/85 mmHg</td>
                        <td>Reflects insulin-driven sodium retention and endothelial stress.</td>
                    </tr>
                    <tr>
                        <td><strong>Fasting Glucose</strong></td>
                        <td>&ge;100 mg/dL</td>
                        <td>Evidence of impaired fasting glucose (IFG).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="berberine">3. Hypoglycemic Botanicals: Berberine vs. Metformin</h2>
        <p>The alkaloid <span class="highlight">Berberine</span> (found in <i>Coptis chinensis</i>, <i>Hydrastis canadensis</i>, and <i>Berberis aristata</i>) is perhaps the most researched botanical for metabolic health. Its mechanism of action closely mirrors Metformin: both activate <span class="highlight">AMPK (Adenosine Monophosphate-activated Protein Kinase)</span>, often called the "metabolic master switch."</p>

        <p>A landmark study published in <i>Metabolism</i> (2008) compared Berberine to Metformin in 36 patients with newly diagnosed Type 2 Diabetes. The results were startling: 0.5g of Berberine taken 3x daily exhibited identical hypoglycemic effects to Metformin. Specifically, Berberine reduced HbA1c from 9.5% to 7.5% over 3 months.</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Insight: The R Pillar (Research)</p>
            <p>A 2021 meta-analysis of 28 randomized controlled trials (n=2,314) found that Berberine significantly reduced FBG by an average of 0.82 mmol/L and HbA1c by 0.65% compared to placebo, with a safety profile comparable to conventional care but with additional benefits for lipid metabolism.</p>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study 1: Reversing the Metabolic Cascade</p>
                    <p class="subtitle">Insulin Resistance & Dyslipidemia</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">R</div>
                    <div class="patient-info">
                        <h4>Robert, 52</h4>
                        <p>Sedentary lifestyle, BMI 31, FBG 118 mg/dL, HbA1c 6.1% (Pre-diabetic).</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Robert was placed on a protocol of 500mg <i>Berberis aristata</i> extract (standardized to 97% Berberine) twice daily with meals. Simultaneously, we introduced 2g of <i>Cinnamomum cassia</i> powder daily.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Robert's FBG dropped to 94 mg/dL and his HbA1c to 5.6% (normal range). Notably, his triglycerides dropped by 42 mg/dL without specific lipid-lowering medication.</p>
            </div>
        </div>

        <h2 id="synergy">4. Organizing Formulas ('O'): Synergistic Glycemic Blends</h2>
        <p>In the R.O.O.T.S. Methodâ„¢, we don't just use "herbal Metformin." We <i>Organize</i> formulas to address multiple pathways of glucose metabolism. Two primary allies for Berberine are <i>Momordica charantia</i> (Bitter Melon) and <i>Cinnamomum cassia</i> (Cinnamon).</p>

        <h3>The Tripartite Glycemic Formula</h3>
        <ul>
            <li><strong>The King (Berberine):</strong> Activates AMPK and increases GLUT-4 expression.</li>
            <li><strong>The Minister (Bitter Melon):</strong> Contains <i>charantin</i> and <i>polypeptide-p</i> (plant insulin) which act directly on glucose uptake and suppress hepatic gluconeogenesis.</li>
            <li><strong>The Messenger (Cinnamon):</strong> Contains water-soluble polyphenol type-A polymers that mimic insulin and enhance the insulin-signaling pathway.</li>
        </ul>

        <p>A 2019 clinical trial demonstrated that <span class="highlight">Cinnamomum cassia</span> at doses of 1-6g per day reduced fasting blood glucose by 10-29% in diabetic patients. This makes it an ideal "Messenger" to improve peripheral sensitivity while Berberine handles the systemic metabolic switch.</p>

        <h2 id="tradition">5. Traditional Wisdom ('T'): The Bitter Reflex</h2>
        <p>Traditional systems (Ayurveda and TCM) have long used the "Bitter" taste to treat "Wasting and Thirsting" disorders (diabetes). This is not merely folklore; it is grounded in the physiology of <span class="highlight">T2R receptors</span> found throughout the gut and even on pancreatic beta cells.</p>

        <p>When we consume bitter tonics (like <i>Gentiana</i> or <i>Taraxacum</i>) before a meal, we trigger the "Bitter Reflex." This stimulates the release of <i>Glucagon-like peptide-1 (GLP-1)</i>, a hormone that increases insulin secretion in a glucose-dependent manner and slows gastric emptying. This is the same pathway targeted by modern "blockbuster" weight loss drugs, but achieved through the R.O.O.T.S. principle of <i>Traditional Wisdom</i>.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸŒ¿</div>
                <div>
                    <p class="box-label">Case Study 2: Postprandial Management</p>
                    <p class="subtitle">Gestational Glucose Support</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>History of PCOS, struggling with high postprandial (after-meal) glucose spikes.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Instead of high-dose alkaloids, we focused on the <i>Bitter Reflex</i>. Sarah used 5ml of a "Bitter Tonic" (Dandelion root, Artichoke leaf, Orange peel) 15 minutes before her largest meal.</p>
                <p><strong>Outcome:</strong> 1-hour postprandial glucose readings dropped from an average of 165 mg/dL to 138 mg/dL. Sarah reported significantly fewer "sugar crashes" and improved satiety after meals.</p>
            </div>
        </div>

        <h2 id="clinical">6. Clinical Application, Safety & Sustainability ('S')</h2>
        <p>When implementing these strategies, the <i>Safety</i> (R) and <i>Sustainability</i> (S) pillars are paramount. Berberine-containing plants are often at risk. For example, <i>Hydrastis canadensis</i> (Goldenseal) is endangered in many regions. As a professional practitioner, you should prioritize <i>Berberis aristata</i> (Indian Barberry) or <i>Coptis chinensis</i>, which are more sustainably cultivated or abundant.</p>

        <h3>Herb-Drug Interactions (HDI)</h3>
        <p>Because Berberine is a potent inhibitor of <span class="highlight">CYP3A4</span> and <span class="highlight">CYP2D6</span> enzymes in the liver, it can increase the serum concentration of many drugs, including cyclosporine and certain blood thinners. Always cross-reference the client's medication list using the <i>Research</i> (R) pillar of the ROOTS framework.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of glycemic herbalism</p>
            
            <div class="question-item">
                <p class="question-text">1. Which molecular transporter is responsible for moving glucose into the cell, and how does Berberine influence it?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.style.display='block'">Reveal Answer</button>
                <div class="answer-text">
                    The transporter is GLUT-4. Berberine activates AMPK, which promotes the translocation of GLUT-4 from intracellular vesicles to the cell membrane, effectively "opening the door" for glucose entry.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. In the R.O.O.T.S. framework, why might we choose Coptis over Goldenseal for glycemic control?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.style.display='block'">Reveal Answer</button>
                <div class="answer-text">
                    This pertains to the 'S' (Sustainability) pillar. Goldenseal (Hydrastis) is an at-risk species, whereas Coptis is more readily cultivated and often contains a higher concentration of Berberine, making it a more ethical and effective choice for chronic metabolic support.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Insulin resistance is primarily a failure of GLUT-4 translocation, often driven by visceral inflammation.</li>
                <li>Berberine (500mg 3x daily) is clinically equivalent to Metformin for HbA1c reduction but offers superior lipid-lowering benefits.</li>
                <li>Synergistic formulas should combine AMPK activators (Berberine) with insulin mimetics (Cinnamon) and hepatic regulators (Bitter Melon).</li>
                <li>Bitter tonics before meals utilize the T2R receptor pathway to stimulate natural GLP-1 release and improve postprandial response.</li>
                <li>Always screen for CYP450 interactions when using high-dose Berberine protocols.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Yin, J., Xing, H., & Ye, J. (2008). "Efficacy of berberine in patients with type 2 diabetes mellitus." <i>Metabolism</i>.</li>
                <li>Lan, J., et al. (2015). "Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension." <i>Journal of Ethnopharmacology</i>.</li>
                <li>Allen, R. W., et al. (2013). "Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis." <i>Annals of Family Medicine</i>.</li>
                <li>Joseph, B., & Jini, D. (2013). "Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency." <i>Asian Pacific Journal of Tropical Disease</i>.</li>
                <li>Zhang, Y., et al. (2021). "Berberine and its role in the management of metabolic syndrome: A comprehensive review." <i>Frontiers in Pharmacology</i>.</li>
                <li>Grundy, S. M., et al. (2005). "Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement." <i>Circulation</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Herbalism Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>